Benefits of patient risk stratification and targeted interventions on multidrug resistant pathogens prevention and control-Reference-Cited by-同舟云学术

Benefits of patient risk stratification and targeted interventions on multidrug resistant pathogens prevention and control

Published:2022-11-14 Issue:1 Volume:1 Page:
ISSN:2731-7501
Container-title:Discover Health Systems
language:en
Short-container-title:Discov Health Systems

Author:

Russo Emanuele^ORCID,Di Bari Silvia^ORCID,Agnoletti Vanni,Bagni Marinella,Bertaccini Barbara,Campagna Deborah,Giacomini Arianna,Magalotti Elisa,Marson Federica,Morena Consuelo,Muccioli Valentina,Paci Giulia,Palazzo Maria Andrea,Pirini Erika,Rasi Alice,Ravaldini Maurizio,Sauchelli Giulia,Spiga Martina,Turrini Claudia,

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s44250-022-00006-6.pdf

Reference40 articles.

1. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.

2. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Committee the HICPA. Management of multidrug-resistant organisms in healthcare settings, 2006. Cent Dis Control Prev. 2018;61(1):26–35.

3. Lone SA, Ahmad A. Candida auris—the growing menace to global health. Mycoses. 2019;62(8):620–37.

4. European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report 2020. Stockholm: ECDC. 2022. https://www.ecdc.europa.eu/sites/default/files/media/en/aboutus/governance/competent-bodies/Documents/coordinating. Accessed 30 Jul 2022.

5. Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol. 2020;41(1):1–18.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献